4.1 Article

Rhinitis Subtypes, Endotypes, and Definitions

Journal

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.iac.2015.12.001

Keywords

Rhinitis; Endotypes; Phenotypes; Pathophysiology; Symptoms

Funding

  1. GSK
  2. Nestle
  3. Merck
  4. AbbVie
  5. Sanofi
  6. Menarini
  7. Meda
  8. Novartis
  9. ALK-Abello
  10. Allergopharma
  11. Uriach
  12. Stallergenes
  13. MSD

Ask authors/readers for more resources

Rhinitis is often seen as posing a small burden. However, rhinitis is a complex disease that is underpinned by a plethora of different mechanisms and causes. Rhinitis is frequently associated with other comorbid conditions but, by itself, is a source of considerable morbidity for patients and creates a significant financial burden on health systems worldwide. This article approaches this condition from both a phenotypic and mechanistic standpoint, focusing on the complexity of characterizing these subtypes. Developing a clearer demarcation of the currently obscure rhinitis phenotypes and endotypes will substantially improve their future prevention and treatment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available